Antinociceptive properties of an oral formulation of Δ9-tetrahydrocannabinol in aqueous 2-hydroxypropyl-β-cyclodextrin in female rats
Farshid BagheriiD, María SchermaiD, Elisabetta MurruiD, Grazia Contena, Sebastiano BanniiD, Antonio ArgiolasiD, Maria Rosaria MelisiD, Paola FaddaiD, Fabrizio SannaiD
Abstract
BackgroundCannabis derivatives have been reported to possess antinociceptive properties. However, oral delivery is limited by poor bioavailability, stability, and reliability of effects. Previously, we reported an analgesic effect of the aqueous complex {Delta}9-tetrahydrocannabinol/2-hydroxypropyl-{beta}-cyclodextrin (THC/HP{beta}CD) after intracerebroventricular administration in male rats. MethodsHere, we investigated the analgesic effects of the THC/HP{beta}CD complex after oral administration (0.3 and 3 mg/kg) by the tail flick test after both acute and chronic administration (15 days) in female rats. Locomotor activity and anxiety-like behavior were also evaluated at the same experimental conditions. Moreover, dopamine and glutamate content in the periaqueductal gray (PAG), a key area for the antinociceptive action of THC, were also measured by HPLC. ResultsAfter acute administration, the antinociceptive effect of the complex was seen at 3 but not 0.3 mg/kg THC, with a maximum effect observed at 30 min (MPE 60%). Similar results were obtained after 15 days of treatment, although partially reduced (max MPE 20%). Reductions in locomotor activity with the dose of 3 mg/kg and a slight biphasic effect of the two doses on anxiety-like behavior were also observed. Finally, neurochemical analyses revealed that the dose of 3 mg/kg significantly increased dopamine and glutamate content in the PAG, an effect no longer present after 15 days of treatment. ConclusionsOur results highlight the antinociceptive efficacy of the THC/HP{beta}CD complex also after oral administration, notably higher than that previously seen with other carriers, although with some degree of tolerance after chronic administration. From a translational point of view, these results are relevant for the development of THC-based oral formulations with analgesic properties for the treatment of pain in humans. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=193 SRC="FIGDIR/small/742765v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@1f8a98corg.highwire.dtl.DTLVardef@433eeeorg.highwire.dtl.DTLVardef@d8b3d0org.highwire.dtl.DTLVardef@1051d1f_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations
C. F. Moore, E. M. Weerts·bioRxiv·May 11, 2021
- Impact of Δ9-tetrahydrocannabinol and oxycodone co-administration on measures of antinociception, dependence, circadian activity, and reward in mice
Richard A. Slivicki, Justin G. Wang, … Robert W. Gereau·Journal of Pharmacology and Experimental TherapeuticsPeer-reviewed·Aug 14, 2026
- Δ9-tetrahydrocannabinol Attenuates Oxycodone Self-Administration Under Extended Access Conditions
Jacques D. Nguyen, Yanabel Grant, … Michael A. Taffe·bioRxiv·Apr 5, 2019
- Antinociceptive, hypothermic, and appetitive effects of vaped and injected Δ9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex
C. F. Moore, C. M. Davis, … E. M. Weerts·bioRxiv·Oct 6, 2020
- Oxycodone Self-Administration in Female Rats is Enhanced by Δ9-tetrahydrocannabinol, but not by Cannabidiol, in a Progressive Ratio Procedure
J. D. Nguyen, Y. Grant, … M. A. Taffe·bioRxiv·Oct 26, 2023
- THC modifies the impact of heroin delivered by vapor inhalation in rats
A. Gutierrez, J. D. Nguyen, … M. A. Taffe·bioRxiv·Apr 26, 2021